A detailed history of Horizon Investment Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Horizon Investment Services, LLC holds 1,836 shares of LLY stock, worth $1.37 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
1,836
Previous 1,836 -0.0%
Holding current value
$1.37 Million
Previous $1.66 Million 2.17%
% of portfolio
0.7%
Previous 0.79%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $4,145 - $5,545
7 Added 0.38%
1,836 $1.43 Million
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $931 - $1,094
3 Added 0.16%
1,829 $628,000
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $59,486 - $69,313
185 Added 11.27%
1,826 $668,000
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $11,985 - $14,072
-43 Reduced 2.55%
1,641 $532,000
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $16,428 - $20,416
-70 Reduced 3.99%
1,684 $482,000
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $2,698 - $3,348
-12 Reduced 0.68%
1,754 $484,000
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $8,420 - $10,362
-38 Reduced 2.11%
1,766 $408,000
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $19,860 - $25,689
-110 Reduced 5.75%
1,804 $414,000
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $1,643 - $2,127
10 Added 0.53%
1,914 $358,000
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $6,523 - $8,631
50 Added 2.7%
1,904 $321,000
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $10,966 - $12,684
-75 Reduced 3.89%
1,854 $274,000
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $44,882 - $54,015
329 Added 20.56%
1,929 $317,000
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $47,620 - $58,940
-400 Reduced 20.0%
1,600 $222,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $213,580 - $232,320
2,000 New
2,000 $224,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Horizon Investment Services, LLC Portfolio

Follow Horizon Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investment Services, LLC with notifications on news.